CDER “Sentencing Guidelines” To Provide Enforcement Clarity
Executive Summary
Janet Woodcock says effort will help standardize its compliance process and ensure penalties fit violations, but one attorney says they may be difficult to implement.
You may also be interested in...
How FDA Plans To Stop Worrying And Love Globalization
New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.
FDA Could Release GMP Data To Prod Manufacturing Improvements
Batch failure and other measures commonly tracked by manufacturers could be aggregated into an industry-wide index that FDA would use to help make risk-based inspection decisions.
Pharmaceutical Quality And Generic Drugs: Janet Woodcock Explains Her Vision
The Office of Generic Drugs may evolve to focus more on clinical issues as the new Office of Pharmaceutical Quality creates uniform standards for manufacturing process engineering and other production areas, the CDER director says in an interview.